Literature DB >> 19690523

Comprehensive self-management for irritable bowel syndrome: randomized trial of in-person vs. combined in-person and telephone sessions.

Monica E Jarrett1, Kevin C Cain, Robert L Burr, Vicky L Hertig, Sheldon N Rosen, Margaret M Heitkemper.   

Abstract

OBJECTIVES: Psychological and behavioral therapies are being increasingly used for symptom management in patients with irritable bowel syndrome (IBS). The aims of this study were to compare two delivery modes for a comprehensive self-management (CSM) intervention, primarily by telephone vs. entirely in person, and to compare each with usual care (UC).
METHODS: Adults with IBS were recruited through community advertisement. Subjects (N=188) were randomly assigned to three groups: one in which all nine weekly CSM sessions were delivered in person, one in which six of the nine sessions were conducted over telephone, and one in which subjects received UC. Primary outcome measures were a gastrointestinal (GI) symptom score based on six symptoms from a daily diary and disease-specific quality of life (QOL). These and other outcomes were assessed at baseline and at 3, 6, and 12 months after randomization. Mixed model analyses tested for differences between the three groups in each outcome variable at the three follow-up occasions, controlling for the baseline level of each outcome.
RESULTS: Both GI symptom score and QOL showed significantly greater improvement in the two CSM groups than in the UC group (P<0.001), with the magnitude of this difference being quite similar for the three follow-up time points. The two CSM groups experienced a very similar degree of improvement, and there were no statistically significant differences between the two.
CONCLUSIONS: A CSM program is efficacious whether delivered primarily by telephone or totally in person, and there is no evidence that replacing six of the in-person sessions by telephone sessions reduces the efficacy of the intervention.

Entities:  

Mesh:

Year:  2009        PMID: 19690523      PMCID: PMC2804069          DOI: 10.1038/ajg.2009.479

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  36 in total

1.  Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.

Authors:  S J Pocock; R Simon
Journal:  Biometrics       Date:  1975-03       Impact factor: 2.571

2.  Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.

Authors:  John T Farrar; James P Young; Linda LaMoreaux; John L Werth; Michael R Poole
Journal:  Pain       Date:  2001-11       Impact factor: 6.961

3.  Cognitive-behaviour therapy as a treatment for irritable bowel syndrome: a pilot study.

Authors:  P Boyce; J Gilchrist; N J Talley; D Rose
Journal:  Aust N Z J Psychiatry       Date:  2000-04       Impact factor: 5.744

4.  The Kaiser Permanente prenatal smoking-cessation trial: when more isn't better, what is enough?

Authors:  D H Ershoff; V P Quinn; N R Boyd; J Stern; M Gregory; D Wirtschafter
Journal:  Am J Prev Med       Date:  1999-10       Impact factor: 5.043

5.  The economic consequences of irritable bowel syndrome: a US employer perspective.

Authors:  Stephanie A Leong; Victoria Barghout; Howard G Birnbaum; Crystal E Thibeault; Rym Ben-Hamadi; Feride Frech; Joshua J Ofman
Journal:  Arch Intern Med       Date:  2003-04-28

6.  Telephone psychotherapy and telephone care management for primary care patients starting antidepressant treatment: a randomized controlled trial.

Authors:  Gregory E Simon; Evette J Ludman; Steve Tutty; Belinda Operskalski; Michael Von Korff
Journal:  JAMA       Date:  2004-08-25       Impact factor: 56.272

7.  Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders.

Authors:  Douglas A Drossman; Brenda B Toner; William E Whitehead; Nicholas E Diamant; Chris B Dalton; Susan Duncan; Shelagh Emmott; Valerie Proffitt; Donna Akman; Karen Frusciante; Terry Le; Kim Meyer; Barbara Bradshaw; Kristi Mikula; Carolyn B Morris; Carlar J Blackman; Yuming Hu; Huanguang Jia; Jim Z Li; Gary G Koch; Shrikant I Bangdiwala
Journal:  Gastroenterology       Date:  2003-07       Impact factor: 22.682

8.  Self-management for women with irritable bowel syndrome.

Authors:  Margaret M Heitkemper; Monica E Jarrett; Rona L Levy; Kevin C Cain; Robert L Burr; Andrew Feld; Pam Barney; Pam Weisman
Journal:  Clin Gastroenterol Hepatol       Date:  2004-07       Impact factor: 11.382

Review 9.  Psychological treatments for the management of irritable bowel syndrome.

Authors:  Ingeborg L Zijdenbos; Niek J de Wit; Geert J van der Heijden; Gregory Rubin; A Otto Quartero
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

10.  Mastery of Your Anxiety and Panic and brief therapist contact in the treatment of panic disorder.

Authors:  Jeffrey E Hecker; Melinda C Losee; Roxann Roberson-Nay; Kristin Maki
Journal:  J Anxiety Disord       Date:  2004
View more
  34 in total

1.  Associations of tryptophan hydroxylase gene polymorphisms with irritable bowel syndrome.

Authors:  S Jun; R Kohen; K C Cain; M E Jarrett; M M Heitkemper
Journal:  Neurogastroenterol Motil       Date:  2010-11-12       Impact factor: 3.598

2.  Rare Variants of the Serotonin Transporter Are Associated With Psychiatric Comorbidity in Irritable Bowel Syndrome.

Authors:  Ruth Kohen; Julia H Tracy; Eric Haugen; Kevin C Cain; Monica E Jarrett; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2016-02-24       Impact factor: 2.522

3.  Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.

Authors:  Young Ah Goo; Kevin Cain; Monica Jarrett; Lynne Smith; Joachim Voss; Ernie Tolentino; Joyce Tsuji; Yihsuan S Tsai; Alexandre Panchaud; David R Goodlett; Robert J Shulman; Margaret Heitkemper
Journal:  J Proteome Res       Date:  2012-10-26       Impact factor: 4.466

4.  [A Meta-Analysis on the Effects of Mind-Body Therapy on Patients with Irritable Bowel Syndrome].

Authors:  Eun Hui Choi; Moon Ja Kim; Eun Nam Lee
Journal:  J Korean Acad Nurs       Date:  2020-06       Impact factor: 0.984

5.  Effect of self-management intervention on cortisol and daily stress levels in irritable bowel syndrome.

Authors:  Wimon Deechakawan; Kevin C Cain; Monica E Jarrett; Robert L Burr; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2011-07-15       Impact factor: 2.522

6.  Comprehensive self-management reduces the negative impact of irritable bowel syndrome symptoms on sexual functioning.

Authors:  Margaret D Eugenio; Sang-Eun Jun; Kevin C Cain; Monica E Jarrett; Margaret M Heitkemper
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

7.  Indirect effect of sleep on abdominal pain through daytime dysfunction in adults with irritable bowel syndrome.

Authors:  Pei-Lin Yang; Robert L Burr; Diana T Buchanan; Kenneth C Pike; Kendra J Kamp; Margaret M Heitkemper
Journal:  J Clin Sleep Med       Date:  2020-10-15       Impact factor: 4.062

8.  Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome.

Authors:  Robert J Shulman; Monica E Jarrett; Kevin C Cain; Elizabeth K Broussard; Margaret M Heitkemper
Journal:  J Gastroenterol       Date:  2014-01-17       Impact factor: 7.527

Review 9.  Effects of Self-Management Interventions in Patients With Irritable Bowel Syndrome: Systematic Review.

Authors:  Xiaomei Cong; Mallory Perry; Katherine M Bernier; Erin E Young; Angela Starkweather
Journal:  West J Nurs Res       Date:  2017-08-30       Impact factor: 1.967

10.  Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention.

Authors:  J Labus; A Gupta; H K Gill; I Posserud; M Mayer; H Raeen; R Bolus; M Simren; B D Naliboff; E A Mayer
Journal:  Aliment Pharmacol Ther       Date:  2012-12-03       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.